The ‘‘Drug Repurposing Service Providers Market, 2020-2030
To order this detailed 250+ page report, please visit this https://www.rootsanalysis.com/reports/drug-repurposing-service-provides.html
Key Inclusions
§ A detailed assessment of the current market landscape ofcompanies offering drug repurposing services based on several relevantparameters, including year of establishment, company size, location ofheadquarters, type of company, type of service offered (drug discovery,consulting and others), purpose of repurposing, type of repurposing andtechnology platform used.
§ A detailed analysis of the various partnerships that havebeen signed within this domain, during the period 2013-2020, along withinformation on year of partnership, type of partnership, and partner company,type of technology / platform used, and key value drivers (such as targettherapeutic area and type of drug molecule) and location of collaborators.
§ A review of recent initiatives undertaken by big pharmaplayers across the globe for the discovery and development of repurposed drugs,along with information on number of initiatives, year of initiative. It alsofeatures a benchmark analysis of top 11 big pharma players (in terms ofannual revenues of 2019), comparing them across various relevantparameters, such as name of repurposed drug, drug class, target therapeuticarea, phase of development and target patient population.
§ A detailed analysis of terminated / withdrawn / suspendeddrug candidates that can be repurposed, based on several relevant parameters,such as current recruitment status, trial phase, cause of discontinuation oftrial, type of sponsor, target therapeutic area(s).
§ A detailed analysis on the cost saving potential of drugrepurposing approaches, as compared to the traditional de novo drug developmentmethods.
§ Elaborate profiles of key players that specialize inoffering services for the development of repurposed drugs. Each profilefeatures an overview of the company (including information on its year ofestablishment, company size and location of headquarters), details on type oftechnology platform used, drug discovery and repurposing focused serviceportfolio, and an informed future outlook.
§ Detailed profiles of key organizations; each profilefeatures an overview of the company (including information on year ofestablishment, location of headquarters, network affiliates and type of serviceoffered), and recent developments related to drug repurposing. It provides briefdiscussion on the various research institutions and non-profit organizationsthat are presently engaged in the drug repurposing domain.
§ An elaboratediscussion on the future opportunities / trends within the drug repurposingservice provider outsourcing market that are likely to influence the growth ofthis domain over the coming years.
The report alsofeatures the likely distribution of the current and forecasted opportunityacross important market segments, mentioned below:
- Type of Repurposing Approaches
§ Disease-centricapproach
§ Target-centricapproach
§ Drug-centricapproach
- Therapeutic Area
§ SameTherapeutic Area
§ DifferentTherapeutic Area
- Type of Drug Molecule
§ Biologics
§ SmallMolecule
- Key Geographical Region
§ NorthAmerica
§ Europe
§ Asia-Pacific
To request sample pages, please visit this https://www.rootsanalysis.com/reports/drug-repurposing-service-provides/request-sample.html
Key Questions Answered
§ Whoare the leading players offering drug repurposing services?
§ Whatkind of initiatives have been undertaken by big pharma players related to drugrepurposing?
§ Whatkind of partnership models are most commonly adopted by stakeholders in thisindustry?
§ Whatis the role of non-profit organizations and academic players in this domain?
§ Whatare the potential cost benefits of drug repurposing, compared to thetraditional drug development process?
§ Whatfactors are likely to influence the evolution of this upcoming market?
§ Howhas the recent COVID-19 pandemic likely impacted the demand for drugrepurposing?
§ How is the currentand future market opportunity likely to be distributed across key marketsegments?
You may also be interested in the following titles:
1. Peptidesand Macrocycle Drug Discovery:Services and Platforms Market, 2020 - 2030
2. ChinaBiopharmaceutical Contract ManufacturingMarket, 2020-2030
3. AntibodyContract Manufacturing Market, 2020 - 2030
Contact Us
Gaurav Chaudhary
+1 (415) 800 3415
gaurav.chaudhary@rootsanalysis.com
